Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
1,020.00    6.00 (0.59%)
Bid:
1,028.00
Ask:
1,030.00
Spread: 2.00 (0.195%)
Market Cap: £146.36b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Delisting from several stock exchanges

25 Jul 2018 07:00

RNS Number : 6892V
Banco Santander S.A.
25 July 2018
 

MATERIAL FACT

 

Banco Santander, S.A. ("Banco Santander") hereby provides notification that its board of directors has decided to request the voluntary delisting of Banco Santander shares (or the instruments that represent them) from the following four stock exchanges (the "Target Markets"):

Stock market

Stock symbol

Security to be delisted

Bolsas y Mercados Argentinos (BYMA)

STD

Shares

B3 S.A. - Brasil, Bolsa, Balcão (Brazil)

BSAN33

Brazilian Depositary Receipts

Euronext Lisbon (Portugal)

SANT

Shares

Borsa Italiana (Italy)

SANT

Shares

Additionally, the board has agreed to request the voluntary delisting of Banco Santander shares listed under the stock symbol SAN in the Índice de Precios y Cotizaciones (IPC) of Bolsa Mexicana de Valores (BMV) and for these shares to be incorporated immediately into BMV, in the Sistema Internacional de Cotizaciones (SIC) available in Mexico for the shares of foreign companies.

These decisions have been taken as part of a process of rationalisation of the markets where Banco Santander has a secondary listing of its shares, and, because of the small volume of Banco Santander shares traded in these markets.

Of the 16,136,153,582 shares into which Banco Santander's share capital is divided, as at 29 June 2018, an aggregate of 50,644,745 shares were registered on the Target Markets, representing 0.314% of the share capital. Furthermore, during 2017, the average daily trading volume on the Target Markets and on Bolsa Mexicana de Valores represented 0.119% of the average overall trading volume of Banco Santander's shares.

Once the corresponding authorisations from each of the supervisors of the Target Markets are obtained, Banco Santander will provide notification in each one of those markets of the effective date of delisting and the pertinent details about the transfer of the shares listed in the stock markets concerned to the Spanish registry system (Iberclear). Similarly, information will be provided on the authorisation and effective date of delisting of Banco Santander shares traded on the Bolsa Mexicana de Valores and their incorporation into the Sistema Internacional de Cotizaciones (SIC).

Due to the delisting from the stock exchanges, and with the aim of adequately protecting the interests of Banco Santander shareholders in the Target Markets, Banco Santander also intends to offer those shareholders the opportunity to sell their shares in the Spanish stock markets (Mercado Continuo) during a period of time no shorter than one month and no longer than three months depending on the jurisdiction, without any costs of intermediation or brokerage and at the listed price at the time when the sale takes place. It is expected that this sale facility will be implemented in the Target Markets on the corresponding dates between August and January 2019, subject to obtaining the relevant authorisations. The details of this sale facility will be notified in each one of the Target Markets in a timely manner once the corresponding authorisations have been obtained.

In any case, Banco Santander shares will continue to be traded in the stock exchanges of Madrid, Barcelona, Bilbao and Valencia, through the Sistema de Interconexión Bursátil Español (Mercado Continuo), New York (where they are listed as ADRs), London (where they are listed as CDIs) and Warsaw.

This decision does not affect the shares of Banco Santander's subsidiaries which are listed on the Target Markets and on Bolsa Mexicana de Valores, where they will continue to be listed without any changes.

 

 

Boadilla del Monte (Madrid), 25 July 2018

 

IMPORTANT INFORMATION

This announcement does not constitute an offer to buy, to sell, to exchange, or a solicitation of offers to buy, to sell, or to exchange Banco Santander shares or any other security. The distribution of this announcement and/or the transfer of Banco Santander shares in some jurisdictions may be restricted by applicable law. Persons who have access to this announcement should be aware of, and comply with, any such restrictions. Any failure to comply with those restrictions may constitute a breach of the securities laws of any such jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCPGUPCMUPRUCA
Date   Source Headline
19th Feb 20247:43 amRNSDividend approval & buyback program implementation
7th Feb 20244:39 pmRNSDirector/PDMR Shareholding
7th Feb 20244:38 pmRNSDirector/PDMR Shareholding
7th Feb 20244:36 pmRNSDirector/PDMR Shareholding
5th Feb 20245:48 pmRNSFurther re capital reduction
1st Feb 20244:46 pmRNSDirector/PDMR Shareholding
31st Jan 20243:55 pmRNSTotal Voting Rights
31st Jan 20247:00 amRNS2023 Results - Press release
31st Jan 20247:00 amRNS2023 Results Report & Earnings Presentation
26th Jan 202411:32 amRNSCapital reduction following completion of program
26th Jan 202411:19 amRNSTransaction in Own Shares
24th Jan 202411:06 amRNSNotice of 2023 Results Presentation
18th Jan 202411:05 amRNSBuyback programme: transactions 11-17 Jan
11th Jan 202411:08 amRNSBuyback programme: transactions 4-10 Jan
4th Jan 202411:07 amRNSBuyback programme: transactions 28 Dec- 3 Jan
29th Dec 202311:58 amRNSTotal Voting Rights
28th Dec 202311:08 amRNSBuyback programme: transactions 21-27 Dec
21st Dec 202311:07 amRNSBuyback programme: transactions 14-20 Dec
20th Dec 20234:14 pmRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSAdapting reporting to new operating model (ppt)
20th Dec 20237:00 amRNSAdapting reporting to new operating model (PR)
18th Dec 20235:22 pmRNSDirector/PDMR Shareholding
18th Dec 20235:17 pmRNSDirector/PDMR Shareholding
18th Dec 20237:05 amRNSDirector/PDMR Shareholding
14th Dec 202311:05 amRNSBuyback programme: transactions 5-13 Dec
13th Dec 20234:41 pmRNSDirector/PDMR Shareholding
13th Dec 20237:02 amRNSOptional early redemption ISIN XS1951093894
11th Dec 202311:24 amRNSSREP Capital Requirements 2024
5th Dec 202311:09 amRNSBuyback programme: transactions 30 Nov – 4 Dec
30th Nov 202311:18 amRNSTotal Voting Rights
30th Nov 202311:12 amRNSBuyback programme: transactions 23-29 Nov
23rd Nov 202311:07 amRNSBuyback programme: transactions 16-22 Nov
22nd Nov 20237:08 amRNSOptional early redemption ISIN XS1692931121
17th Nov 20237:00 amRNSAT1s Contingent Convertible securities
16th Nov 20232:24 pmRNSBuyback programme: transactions 8-15 Nov
16th Nov 202311:06 amRNSBuyback programme: transactions 8-15 Nov
8th Nov 202311:06 amRNSBuyback programme: transactions 31 Oct – 7 Nov
31st Oct 202312:03 pmRNSTotal Voting Rights
31st Oct 202310:14 amRNSBuyback programme: transactions 26–30 Oct
26th Oct 202312:09 pmRNSTotal Voting Rights
26th Oct 202311:05 amRNSBuyback programme: transactions 19 Oct – 25 Oct
25th Oct 20237:00 amRNS3Q 2023 Results Report & Earnings Presentation
25th Oct 20237:00 amRNS3rd Quarter 2023 Results - Press release
19th Oct 202311:08 amRNSBuyback programme: transactions 11 Oct – 18 Oct
18th Oct 202311:11 amRNSNotice of Third Quarter 2023 Results
11th Oct 202311:27 amRNSBuyback programme: transactions 5 Oct – 10 Oct
5th Oct 202311:41 amRNSBuyback programme: transactions 28 Sep – 4 Oct
29th Sep 202311:06 amRNSTotal Voting Rights
27th Sep 20236:31 pmRNSCommencement of a program to repurchase own shares
27th Sep 20237:00 amRNSFurther re dividend approval

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.